TRLS-09. RTOG1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY IN COMBINATION WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM HER2-POSITIVE BREAST CANCER

The addition of trastuzumab to cytotoxic chemotherapy has improved outcomes for patients with HER2 positive breast cancer. Increased survival coupled with limited blood-brain barrier (BBB) penetration of trastuzumab may contribute to the increased incidence of brain metastasis in these patients. Hal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, In Ah, Winter, Kathryn, Peereboom, David, Sperduto, Paul, De Los Santos, Jennifer, Ogunleye, Tomi, Boulter, Daniel, White, Julia, Mehta, Minesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213269/
http://dx.doi.org/10.1093/noajnl/vdz014.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213269/
http://dx.doi.org/10.1093/noajnl/vdz014.042

Ejemplares similares